Breast cancer drug halves disease risk in post-menopausal women

A new study has shown that taking the breast cancer drug anastrozole for five years reduces the chances of developing the disease in high risk post-menopausal women by 53 percent compared with women who took a placebo.

Breast cancer drug toxic to brain cells and central nervous system

Researchers have revealed that the breast cancer drug tamoxifen is toxic to cells of the brain and central nervous system, and produces mental fogginess similar to "chemo brain."

Roche not to pursue patent for breast cancer drug in India

Swiss pharma major Roche Holding AG today said it won`t pursue the secondary patent for its breast cancer drug `Herceptin` in India.

FDA says breast cancer drug did not extend lives

Federal health scientists said on Friday that follow-up studies of a Roche breast cancer drug showed that it failed extend patient lives.

FDA says breast cancer drug did not extend lives

Federal health scientists said on Friday that follow-up studies of a Roche breast cancer drug showed that it failed extend patient lives.